These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 26843058)
41. Aberrant expression of tumor suppressor proteins in the Ewing family of tumors. Maitra A; Roberts H; Weinberg AG; Geradts J Arch Pathol Lab Med; 2001 Sep; 125(9):1207-12. PubMed ID: 11520274 [TBL] [Abstract][Full Text] [Related]
42. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Zhou HW; Lou SQ; Zhang K Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580 [TBL] [Abstract][Full Text] [Related]
43. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas. Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229 [TBL] [Abstract][Full Text] [Related]
44. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661 [TBL] [Abstract][Full Text] [Related]
47. p16INK⁴a and p14ARF mRNA expression in Pap smears is age-related. von Keyserling H; Kühn W; Schneider A; Bergmann T; Kaufmann AM Mod Pathol; 2012 Mar; 25(3):465-70. PubMed ID: 22080060 [TBL] [Abstract][Full Text] [Related]
48. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335 [TBL] [Abstract][Full Text] [Related]
49. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma. Chang DT; Chapman CH; Norton JA; Visser B; Fisher GA; Kunz P; Ford JM; Koong AC; Pai RK Cancer; 2010 Nov; 116(22):5179-87. PubMed ID: 20665497 [TBL] [Abstract][Full Text] [Related]
50. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681 [TBL] [Abstract][Full Text] [Related]
51. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482 [TBL] [Abstract][Full Text] [Related]
52. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma]. Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849 [TBL] [Abstract][Full Text] [Related]
53. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247 [TBL] [Abstract][Full Text] [Related]
54. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682 [TBL] [Abstract][Full Text] [Related]
55. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia. Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528 [TBL] [Abstract][Full Text] [Related]
56. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729 [TBL] [Abstract][Full Text] [Related]
57. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma. Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964 [TBL] [Abstract][Full Text] [Related]
58. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast. Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113 [TBL] [Abstract][Full Text] [Related]
59. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P; Zaravinos A; Zioga M; Spandidos DA Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278 [TBL] [Abstract][Full Text] [Related]
60. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]